A Discussion with Carlos Chaccour: Ivermectin and COVID-19, Scientific Rigor in Times of Urgency | Podcast S2 E 24

Jun 3, 2020 | Digital Media, Podcast

Carlos Chaccour TSN
In this episode Carlos Chaccour will talk about potential Ivermectin use for COVID-19, the safety of Ivermectin, potential Ivermectin use for malaria, Ivermectin use for other communicable diseases and other potential uses of ivermectin.
You can view more about Carlos Chaccour below:

Read more here:

Spanish Research Center Launches Ivermectin Clinical Trial Targeting Mild COVID-19 Patients

1 Comment

  1. Konstantin

    Ivermectin at a dosage of 300 μg / kg of the patient’s weight (0.05% solution), introduced into the patient’s lungs by several inhalations in combination with a caletra, removes viral load from the lungs within 72 hours. With the early start of such treatment, recovery occurs in 36-48 hours.
    For moderate to severe disease, anticoagulants, IL-6 blockers, antibiotics, vitamin C, zinc, and heavy drinking or saline injections are needed.

Pin It on Pinterest